If you can spare a few minutes, please help us improve our website by completing this survey.
June 14, 2017
With the future of federal funding for biomedical research under constant scrutiny, many members of the KI community are stepping out of the lab and into the fray. This spring, the Koehler Lab’s Shelby Doyle joined the MIT Science Policy Initiative on an advocacy trip to Washington, D.C. to learn about the legislative process and how to interact with policy makers to better serve the science and engineering community. KI faculty members Tyler Jacks (who testified in front of the House Committee on Oversight and Government Reform to advocate for federally funded cancer research earlier this year), Robert Langer, Phillip Sharp, and Robert Weinberg — along with Gertler Lab postdoc Madeleine Oudin and former Langer Lab postdocs Omid Veiseh and Jeffrey Karp — spoke with The Boston Globe about NIH's controversial plan to cap the number of grants awarded to larger, more established labs. The plan was ultimately abandoned in favor of new programs like the Next Generation Researchers Initiative, which will provide dedicated funding to early- and mid-career investigators. By speaking out and working together, researchers at all levels have the ability to change the course of cancer — and of cancer research.